Four patients who did not meet any of the AKIN criteria but had a significant elevation of plasma NGAL (above the cut-off of 200 ng/mL) have been placed in a separate group defined as Subclinical AKI (Figure 2(d)). This evidence concerns the gene LCN2 and acute kidney injury.